Within the GHPP-project SENSE (Strengthening National Immunisation Technical Advisory Groups and their evidence-based decision making in the WHO European Region and globally), the unit FG 33 welcomed a delegation of the Kyrgyz National Immunisation Technical Advisory Group (NITAG) at the Robert Koch Institute in Berlin from the 9 to 10…
Short Description Multidrug-resistant (MDR) and extensively drug-resistant (XDR) tuberculosis (TB) represent an increasing threat for global tuberculosis (TB) control. Successful control of M/XDR-TB requires efficient drug susceptibility testing (DST) as basis for designing effective therapy regimens. However, e.g. due to inadequate infrastructure, DST is often missing or delayed in countries…
Short Description In the European Vaccine Action Plan, the WHO defined hepatitis B control through immunization as one of the major strategic goals. The WHO/EURO Action Plan for response to viral hepatitis sets the goal of elimination of viral hepatitis as a public health threat by 2030. It also sets…
Short Description COVID-19 strongly affects the living conditions of people, showing the value of reliable and timely information. The burden of disease (BoD) methodology is a suitable instrument to monitor the impact of the COVID-19 pandemic on population health, but while illness and death impose a considerable impact, the disease…
Short Description The COVID-19 pandemic has significantly impacted the national health and care systems in hepatitis control. The need to reallocate resources and personnel, decreased accessibility to services, and temporarily reduced supplies of tests and medications are likely to have far-reaching consequences for other disease areas, including viral hepatitis.
Short Description National Immunisation Technical Advisory Groups (NITAGs) are multidisciplinary panels of national experts providing independent and evidence-based guidance to Ministries of Health on immunisation policies and vaccine use in the population. The main task of the NITAGs is to gather, review, evaluate and structure evidence on specific vaccination topics…
From 31 October to 4 November 2022, an RKI-team from the WHO Collaborating Center for Viral Hepatitis and HIV travelled to Yerevan, Armenia, for the project COVIMPACT Hepatitis “Assessing the impact of COVID-19 pandemic on viral hepatitis B and C elimination efforts in Eastern…
What is the structure of the project, how do people work together? The project is co-coordinated by Professor Milena Santric Milicevic in Belgrade, Serbia and Professor Kairat Davletov in Almaty, Kazakhstan. Together with the RKI team, they and their staff form the steering group. At the beginning of the project,…
From 17 – 21 October 2022, the RKI organised a joint evaluation workshop for the GHPP project COVIMPACT Hepatitis “Assessing the impact of COVID-19 pandemic on viral hepatitis B and C elimination efforts in Eastern Europe and Central Asia”. Project partners from Armenia, Georgia, Kyrgyzstan, Ukraine and Uzbekistan from the…